Summary It has been proposed that nm23-H 1, a candidate suppressor gene for metastasis, plays an important role in metastasis formation of human tumours. In order to investigate its role in the progression of colorectal cancer, we analysed 22 liver metastases of this malignancy with respect to mutational changes, loss of heterozygosity and expression levels of nm23-H 1. Although genetic alterations in nm23-H I have recently been described in those colorectal adenocarcinomas which give rise to distant metastases, we were unable to detect any mutation in the coding sequence of nm23-Hl in the metastatic tissue itself. We further analysed the metastases with respect to allelic deletions at the chromosomal locus of nm23. However, no loss of heterozygosity could be detected in ten informative cases. Moreover, the mRNA expression levels of nm23-Hl in the metastatic tissues were not significantly different from those in normal colon mucosa. Thus, although nm23-Hl might be involved in metastasis suppression of certain tumour types, in colorectal tumour progression its role remains to be determined.
The discovery of genetic alterations in oncogenes and tumour-suppressor genes, which accompany tumour formation in a wide variety of human tumour types, has encouraged the search for genes that may promote or suppress tumour spread and metastasis. Among these, nm23 seemed to be the most promising candidate for a gene with metastasis-suppressing function. There are two closely related human homologues of this gene, called nm23-H1 and nm23-H2, both of which map to the chromosomal locus 17q21.3 (Backer et al., 1993) . Nm23 proteins have been demonstrated to have nucleoside diphosphate kinase (NDP kinase) activity (Biggs et al., 1990; Lacombe et al., 1990; Gilles et al., 1991) and the human Nm23-H2 gene product has recently been identified as the c-myc transcription factor PuF (Postel et al., 1993) .
Reduced expression levels of nm23-H1 mRNA and allelic deletions at the chromosomal locus 17q21.3, which might abrogate the suppressor function, have been implicated in metastasis formation of several human tumour types (Bevilacqua et al., 1989; Cohn et al., 1991; Hennessy et al., 1991; Hirayama et al., 1991; Leone et al., 1991; Nakayama et al., 1992) . In breast carcinomas, for example, low nm23-Hl mRNA levels have been associated with the presence of lymph node metastases (Bevilacqua et al., 1989) , while high mRNA levels have been correlated with good prognosis (Hennessy et al., 1991; Hirayama et al., 1991) .
The data published so far, are, however, somewhat contradictory, since increased nm23-H 1 expression has been observed in several tumour types, including colon cancer (Haut et al., 1991; Lacombe et al., 1991; Myeroff & Markowitz, 1993) . In some tumours this increased expression has even been associated with poor prognosis. In neuroblastoma, for instance, overexpression of the nm23-H1-encoded protein has been correlated with advanced stage disease (Hailat et al., 1991; Leone et al., 1993) . In colon cancer, low expression levels of nm23-H1 have been associated in metastasis formation in some studies (Yamaguchi et al., 1993) , while other groups did not find differences between the expression levels of colon tumours with low and high metastatic potential (Haut et al., 1991) . Moreover, the role of mutations detected in nm23 is controversial. Recently published data generated on primary colon cancer suggest that mutations of nm23-H1 may be associated with metastasis (Wang et al., 1993) . However, with the aid of screening methods, other groups were unable to detect any mutation in both nm23 homologues in primary colon carcinomas of low and high metastatic potential (Myeroff & Markowitz, 1993 To further clarify the role nm23-H 1 mutations play in the progression of colorectal cancer, we analysed metastases of this malignancy. We sequenced the whole coding sequence of nm23-Hl in 22 liver metastases and determined the allele number at the nm23 locus. Furthermore, we measured nm23-Hi -mRNA levels using a sensitive polymerase chain reaction (PCR) assay and quantitative high-performance liquid chromatography (HPLC).
Materials and methods
RNA isolation and sequencing Fresh-frozen tumour tissues from 22 patients undergoing abdominal surgery were sliced with a cryostat. Areas showing a high tumour cell content were pooled; the tumour cell content was estimated on the basis of haemalum-stained tissue sections (Table I) . Total RNA was isolated from homogenised tissue (RNAzol-kit/Cinna Biotecx Laboratories, Houston, TX, USA), reverse transcribed into cDNA (M-MLV-Reverse Transcriptase, Gibco/BRL, Bethesda, MD, USA) and cDNA sequences corresponding to the coding region of nm23 were PCR amplified (primer sequences shown below). Primer pairs nmHl-l/nmHl-2 and nmHl-3/nmHl-4 were used to amplify the 5' half and the 3' half of nm23-H1 respectively. The reactions were performed with decreasing annealing temperature (starting at 60'C, going down 1 degree every second cycle to 56°C, then one cycle at 55'C and one at 54'C followed by 23 cycles at 53'C). PCR products were purified (Gene Clean-kit, Bio 101, La Jolla, 'CA, USA) and bound via biotin-streptavidin binding to magnetic particles (Dynabeads M-280, Dynal, Hamburg, Germany). Singlestranded templates for sequencing were generated by alkaline denaturation and magnetic separation of the strands using the protocol for solid-phase sequencing of Dynal. Sequence reactions were performed using the Sequenase 2.0 kit of USB (Cleveland, OH, USA) based on the Sanger dideoxy chaintermination method.
Loss of heterozygosity Loss of nm23 alleles was determined using the chromosomal marker MPO/q21-23 (Polymeropoulos et al., 1991 (Sambrook et al., 1989 ).
mRNA expression
Nm23-H 1 -mRNA concentration was determined using a differential PCR assay (Frye et al., 1989; Neubauer et al., 1990) : cDNA sequences of the target gene nm23-Hl (primer pair nmH1-3/nmH1-4) and a reference gene (P-actin) were co-amplified in the same reaction vessel. The ratio of the intensities of the two resulting bands indicated the relative gene expression of nm23-H1. Quantitation of PCR products was performed via determination of the optical density at 260 nm after separation of the PCR products by means of HPLC, using the TSK-DEAE-NPR column of Perkin Elmer Cetus.
Primer sequences nmHl-l nmH1-2 nmH1-3 nmH1-4 P-Actin-5' P-Actin-3'
5'-CACAGCTTCAGAAGTCACAG-3' The P-actin and MPO primer sequences were taken as described (O'Bryan et al., 1991; Polymeropoulos et al., 1991) .
Results

Sequence analysis
With the aid of the primer pairs NmH 1-1/NmH 1-2 and NmH 1-3/NmH 1-4, PCR products were generated which spanned the whole coding region of nm23-H 1. Direct sequencing of these PCR products revealed no genetic alteration in the nm23-HI coding sequence. Neither point mutations nor deletions could be detected. Since the sequence was of high resolving quality over the whole coding region (Figure 1) , we can exclude the possibility of minor mutant bands which might be weakened by contaminating normal tissue.
In the literature, nucleotide changes that lead to an amino acid exchange have been described in only two cases. First, a mutation at amino acid position 48 of nm23-H2, which is 88% identical to nm23-Hl (Stahl et al., 1991) , has recently been found in a childhood neuroblastoma (Leone et al., 1993) . Second, the proline at amino acid position 96 is homologous to proline 97 of the Drosophila homologue, which is 78% identical to human nm23-HI (Rosengard et al., 1989) . Mutation of this gene in the Drosophila mutant abnormal wing disc (awd) affects the development of multiple tissues at a stage when the presumptive adult tissues begin to divide and differentiate (Dearolf et al., 1988) . However, analysing our sequence autoradiographs did not reveal any mutation in the coding sequence of nm23-Hl in 22 metastatic tissues.
Figure 1 Sequence of nm23-Hl cDNA extending from codon 42 to codon 100 derived from two metastatic liver tissues of two patients. No mutation could be detected in codons 48 and 96, which have been described to be mutated in a human neuroblastoma and a Drosophila mutant respectively. nm23-HJ mRNA expression Nm23-H1 mRNA levels were determined with tI differential PCR assay (Frye et al., 1989; Neub 1990) : cDNA sequences of the target gene nm22 reference gene (fi-actin) were co-amplified in the tion vessel; the ratio of the intensities of the tw bands indicated the relative gene expression ol (Figure 3 ). PCR products were quantified using resulting values are summarised in Table I However, although we also compared our data v mucosa, the relative expression levels in both studi be directly comparable owing to different stan methods. Figure 3 Relative mRNA expression of nm23-H 1. The cDNA sequences of the target gene nm23-H I and a reference gene (,-actin) were co-amplified in the same reaction vessel. The ratio of the intensities of the two resulting bands indicated the relative gene expression of nm23-HI. nj-n3, normal colon mucosa of three patients with primary colorectal cancer; 1-72, unit patient numbers used in Table I (Ayhan et al., 1993) . This, however, seems necessary to meet te nm23-Hl different functions of both genes in the cell (Postel et al., liver meta-1993 (Frye et al., 1989; Neubauer et al., 1990) . Using this assay we found that only a third (7 of 21) of the probes analysed had relative expression levels which exceeded 1.5. Our results differ from those published recently on primary colon cancer with respect to fre--123 bp quency of overexpression and mRNA levels kowitz, 1993) which could be because of the different methods used by these authors. However, our data also provide evidence in favour of overexpression rather than underexpression, which seems to be in contrast to the supposed role of nm23-H1 as a metastasis suppressor. This is reminiscent of the tumour-suppressor protein p53, overexpression of mutated forms of which results in complex dtof tandem formation with wild-type p53, thereby abrogating wild-type 3el electrosuppressor function (Levine et al., 1991) . However, since we mers flankdid not find any mutation, overexpression of nm23-H1 could ,f 10 ng of not be explained by such dominant negative effects. Furthermetastatic more, cell clones isolated from human colon carcinomas have ft and right been shown to express similar levels of nm23-H 1 mRNA regardless of metastatic potential in nude mice (Radinsky et al., 1992) . Thus, the significance of overexpression of nm23-HI in the course of tumour progression has to be questioned in colorectal carcinogenesis. Although allelic deletions of nm23-Hl in primary colon tumours have been associated with distant metastases (Cohn et al., 1991) we were unable to detect loss of heterozygosity at the 17q21-23 locus in metastases. This could be because of the chromosomal marker we used in this study, which is not localised directly at the nm23-H1 locus but at the nearby MPO locus (Polymeropoulos et al., 1991) . However, since allelic deletions found in human tumours frequently comprise large chromosomal regions, it is remarkable, that none of the ten probes we analysed showed loss of heterozygosity at the 17q21-23 locus. Since several important genes that undergo frequent rearrangements and presumably play a role in tumorigenesis also map to 17q21 (Backer et al., 1993) nm23-HI may not be the primary target of allelic deletion in colorectal tumours.
Thus, the importance of nm23 in tumour progression of colorectal cancer has to be questioned. The data published so far indicate that, at least in some tumour types, including colon cancer, nm23 does not play a major role in the suppression of metastasis. However, it may be possible that metastasis suppression by nm23 is a tissue-specific phenomenon which occurs only in some tumour types via nm23, while other tissues use different pathways.
This work was supported by the Wilhelm-Sander Stiftung, Neustadt a. d. Donau, Germany.
